乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

EASD

<乌鸦传媒>Eye Damage Can Start in Prediabetes

Study found significant corneal nerve damage even before full-blown type 2 diabetes

<乌鸦传媒>Diabetes Risk With Breastmilk, Antidepressants, Weight Loss

A roundup of noteworthy research from the EASD 2021 meeting

<乌鸦传媒>Gender Differences Seen With CV Prevention in Diabetes

Clues from post-hoc analysis of the REWIND trial

<乌鸦传媒>Why Bariatric Surgery's Mortality Risk Is Higher in Men

Age, worse overall health at operation time appear to play a part

<乌鸦传媒>Could a Bisphosphonate Prevent Type 2 Diabetes?

Study finds association between alendronate use and future diabetes risk

<乌鸦传媒>Healthy Lifestyle Keeps Dementia at Bay in Patients With Diabetes

Maintaining control of risk factors neutralized excess dementia risk

<乌鸦传媒>Proxy Measure of Insulin Resistance Predictive of Stroke

Study found relationship between estimated glucose disposal rate and first-time stroke

<乌鸦传媒>Britons With Type 1 Diabetes Die Nearly 8 Years Earlier

But keeping HbA1c in check can mitigate this early mortality

<乌鸦传媒>Novel Once-Weekly Insulin Shines for Type 2 Diabetes

Phase II study compared with daily insulin glargine U100

<乌鸦传媒>Dapagliflozin: More Good News in HF

SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use

<乌鸦传媒>Linagliptin CV Safety; Insulin Storage; Renal Outcomes

Round-up of more top research from the 2018 EASD meeting

<乌鸦传媒>Dual GIP/GLP-1 Agonist Succeeds in T2D Trial

Novel diabetes treatment improved HbA1c, aided in weight loss

<乌鸦传媒>Weight Loss Drug Helped Prevent Diabetes in Overweight People

Lorcaserin lowered T2D risk in those with normoglycemia, prediabetes

<乌鸦传媒>Death Risk Elevated in Dementia Patients with Hypoglycemia

Target hypoglycemic episodes instead of HbA1c, researchers urge

<乌鸦传媒>Deaths from Non-Obesity-Related Cancers Higher in T2D

Even in some obesity-related malignancies, high BMI was inversely tied to cancer death

<乌鸦传媒>Heart Benefit Seen with GLP-1 RA Albiglutide

Significant reduction in myocardial infarctions; will drug be brought back to market?

<乌鸦传媒>In Brief: Four EASD Trials to Note

Aggressive therapy cuts range of risk factors; caffeine tied to mortality benefit; and more

<乌鸦传媒>CV Benefit from PCSK9 Drug Unaltered by Diabetes

Nor did evolocumab hike diabetes risk in FOURIER cohort

<乌鸦传媒>Dietary Sodium Tied to New-Onset Diabetes Risk

Higher rates of type 2 and late autoimmune diabetes in adults with increasing sodium

<乌鸦传媒>Sugar Substitutes: Not So Sweet for Glucose Absorption?

Artificial sweeteners may have negative effect on glycemic control

<乌鸦传媒>T2D Tied to Less Aortic Aneurysm Risk

Does diabetes somehow strengthen vessel wall?

<乌鸦传媒>Diabetes Targets Hard to Meet in Transgender Population

Hormone therapy tied to increased modifiable risks

<乌鸦传媒>Novel Intestinal Sleeve Improves Weight and T2D Control In Real World

Small U.K. study suggests benefits in real-world use

<乌鸦传媒>A1c, Weight Loss Benefit Seen With Exenatide-Glargine Combo

No increased risk for hypoglycemia reported

<乌鸦传媒>EASD Imposes Tight Security Outside, Embraces Twitter Inside

ADA overreacted to online slide sharing, EASD leaders say

<乌鸦传媒>Longer-Term Home Use Safe for Artificial Pancreas System

3-month study might pave way to FDA clearance

<乌鸦传媒>Another GLP-1 Wins on Cardio Prevention

Novel semaglutide reduced major CV event risk in large outcomes trial

<乌鸦传媒>Januvia/Metformin Combo Gets Boost from Novel SGLT2

T2D patients uncontrolled on duo do better when adding ertugliflozin

<乌鸦传媒>CGM for T1D Reduces Hypoglycemia

Less time outside range for reduced hypo awareness patients in trial

<乌鸦传媒>Switching GLP-1 For DPP-4 Improves Net T2D Outcomes

Victoza bests Januvia for combo therapy on A1c, weight, hypoglycemia composite

<乌鸦传媒>EASD: Gestational Diabetes Guidelines Controversial

LISBON -- International guidelines on screening for gestational diabetes that will likely raise the prevalence of the condition have sparked questions over appropriate diagnostic tools and cost efficacy, researchers said here.